Ownership

Marsha Fanucci - Insider Trading & Ownership

Entity: Individual
Location: Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, MA
Summary: The estimated net worth of Marsha Fanucci is at least $79.2K dollars as of June 7, 2024. Marsha Fanucci is the Director of Syros Pharmaceuticals, Inc. and owns shares of Syros Pharmaceuticals, Inc. (SYRS) stock worth about $79.2K.
All Insider Reports: All Insider Reports

Ownership of Marsha Fanucci

Symbol	Company	Relationship	Holdings Value	Report Period
SYRS	Syros Pharmaceuticals, Inc.	Director	$79.2K	Jun 5, 2024
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Director		May 18, 2023
CYCN	Cyclerion Therapeutics, Inc.	Director		Jun 14, 2022
FMTX	Forma Therapeutics Holdings, Inc.	Director		Oct 14, 2022

Showing 1 to 4 of 4 entries

Insider Transactions Reported by Marsha Fanucci:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
SYRS	Syros Pharmaceuticals, Inc.	Common Stock	Award	+33.3%	$0	0.00	+4K	16K	6/5/2024	Direct
SYRS	Syros Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+6K	6K	6/5/2024	Direct
SYRS	Syros Pharmaceuticals, Inc.	Common Stock	Award	+50%	$0	0.00	+4K	12K	6/1/2023	Direct
SYRS	Syros Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+6K	6K	6/1/2023	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+3.45K	3.45K	5/18/2023	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Common Stock	Options Exercise		$0	0.00	+136	136	2/23/2023	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Restricted Stock Units	Options Exercise	-100%	$0	0.00^*	-136	0	2/23/2023	Direct
FMTX	Forma Therapeutics Holdings, Inc.	Common Stock	Disposition pursuant to a tender of shares in a change of control transaction	-100%	$0		-59.8K	0	10/14/2022	Direct
FMTX	Forma Therapeutics Holdings, Inc.	Stock Option (Right to Buy)	Disposed to Issuer	-100%	$0		-74.7K	0	10/14/2022	Direct
SYRS	Syros Pharmaceuticals, Inc.	Common Stock	Award		$0	0.00	+8K	8K	9/16/2022	Direct
SYRS	Syros Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+12K	12K	9/16/2022	Direct
CYCN	Cyclerion Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+20K	20K	6/14/2022	Direct
FMTX	Forma Therapeutics Holdings, Inc.	Common Stock	Award	+8.14%	$0	0.00	+4.5K	59.8K	6/8/2022	Direct
FMTX	Forma Therapeutics Holdings, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+6.75K	6.75K	6/8/2022	Direct
SYRS	Syros Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+17.5K	17.5K	6/1/2022	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+5.15K	5.15K	5/18/2022	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Restricted Stock Units	Award		$0	0.00	+136	136	2/23/2022	Direct
ALNY	Alnylam Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+4.03K	4.03K	7/15/2021	Direct
CYCN	Cyclerion Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+10K	10K	6/24/2021	Direct
FMTX	Forma Therapeutics Holdings, Inc.	Common Stock	Award	+5.23%	$0	0.00	+2.75K	55.3K	6/17/2021	Direct
FMTX	Forma Therapeutics Holdings, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+8.38K	8.38K	6/17/2021	Direct
SYRS	Syros Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+17.5K	17.5K	6/8/2021	Direct

Previous1Next

Showing 1 to 22 of 22 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.